NCT00227188View on ClinicalTrials.gov

Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.

CompletedOBSERVATIONAL
Enrollment

408

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Invasive Pneumococcal Disease
Interventions
DRUG

Pneumococcal 7-valent conjugate vaccine Prevnar

Trial Locations (1)

48903

Pfizer Investigational Site, Bilbao

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY